SCHEMBL4138826

SCHEMBL4138826

COC(=O)c1cnc(-c2ccc(-c3nc4ccc(C(F)(F)F)cc4[nH]3)nc2)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 6/20 0.48
DGAT1 O75907 6/20 0.48
KCNH2 Q12809 2/20 0.46
SOAT1 P35610 1/20 0.46
RHEB Q15382 1/20 0.46
CBFB Q13951 1/20 0.45
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
MMP13 P45452 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
AGPAT2 O15120 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4155027 0.92 RHEB (0.47) DGAT1KCNH2SOAT1RHEBMMP2
SCHEMBL4156087 0.91 RHEB (0.54) NPBWR1DGAT1KCNH2SOAT1RHEB
SCHEMBL4156776 0.89 NPBWR1 (0.51) NPBWR1DGAT1KCNH2SOAT1CBFB
SCHEMBL4151516 0.87 NPBWR1 (0.46) NPBWR1DGAT1KCNH2SOAT1CBFB
SCHEMBL4142862 0.86 MMP2 (0.60) DGAT1KCNH2SOAT1RHEBCBFB
SCHEMBL15252923 0.86 DGAT1 (0.49) NPBWR1DGAT1KCNH2SOAT1CBFB
SCHEMBL4157118 0.85 CBFB (0.41) DGAT1RHEBCBFBMMP2MMP9
SCHEMBL13741532 0.85 SMN1; SMN2 (0.56) DGAT1RHEBMMP2MMP9MMP8
SCHEMBL4181974 0.84 NPBWR1 (0.57) NPBWR1DGAT1KCNH2SOAT1CBFB
SCHEMBL15252715 0.83 DGAT1 (0.53) NPBWR1DGAT1KCNH2SOAT1CBFB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054405-B1 NOVEL BIARYL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2013-09-18 EP claimed
US-20090209540-A1 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2009-08-20 US claimed
US-8940769-B2 Biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-01-27 US disclosed
US-20130217684-A1 NOVEL BIARYL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2013-08-22 US disclosed
US-8436022-B2 Biaryl benzolmidazole derivatives and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2013-05-07 US disclosed
US-20090209540-A1 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209540-A1 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same TRPV1, TRPV3, TRPV5 NPBWR1 840/4885DGAT1 2497/4885KCNH2 280/4885
US-20130217684-A1 NOVEL BIARYL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME TRPV1, TRPV3, TRPA1 NPBWR1 383/4885DGAT1 3064/4885KCNH2 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.